CIBC World Market
DFTX

CIBC World Market’s Definium Therapeutics DFTX Stock Holding History

CIBC World Market’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$462K Sell
9,827
-222
-2% -$5.49K ﹤0.01% 1233
2026
Q1 		$190K Buy
+10,049
New +$171K ﹤0.01% 1404
2022
Q3 		– Sell
-1,215
Closed -$11.7K – 1291
2022
Q2 		$12K Buy
1,215
+1
+0.1% +$13 ﹤0.01% 1251
2022
Q1 		$20K Buy
1,214
+178
+17% +$3.09K ﹤0.01% 1285
2021
Q4 		$21K Buy
1,036
+11
+1% +$351 ﹤0.01% 1309
2021
Q3 		$36K Buy
+1,025
New +$44.3K ﹤0.01% 1313

Other funds holding DFTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

CIBC World Market's DFTX Position: Q2 2026 in Review

CIBC World Market reduced its Definium Therapeutics (DFTX) stake by 2.2% in Q2 2026, selling an estimated $5.49K and leaving 9,827 shares worth $462K. The position accounts for ﹤0.01% of the portfolio, ranked #1233.

CIBC World Market first reported a position in DFTX in Q3 2021 and has held it in 6 quarters since. 361 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

  • CIBC World Market held 9,827 shares of Definium Therapeutics worth $462K as of Q2 2026.
  • CIBC World Market sold 222 Definium Therapeutics shares in Q2 2026, an estimated $5.49K.
  • Definium Therapeutics made up ﹤0.01% of CIBC World Market's portfolio in Q2 2026, its #1233 holding.
  • CIBC World Market first reported a position in Definium Therapeutics in Q3 2021 and has held it in 6 quarters since.
  • 361 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on CIBC World Market's 13F filing for Q2 2026, filed 13 Aug 2026.